Article
Mutations in immunodeficiency-related genes may increase the risk of infection after CAR-T-cell therapy: a report of two cases.
BMC infectious diseases - 22 Feb 2023
Wang Di, He Li, Li Chunhui, Xu Menglei, Yu Qiuxia, Almeida Varlene Daniela Fernandes, Que Yimei, Xu Yanjie, Xiao Yi, Li Chunrui
Abstract excerpt
BACKGROUND: Chimeric antigen receptor T-cell therapy (CAR-T) has yielded unprecedented efficacy in B-cell malignancies. With the increasing use of CAR-T-cell therapy, infection has become one of the major concerns after CAR-T-cell infusion. Some patients even develop refractory or recurrent infections, posing challenges in treatment, prophylactic, and monitoring strategies. However, the mechanisms underlying the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
